Turing refuses to reduce the price of Daraprim
Turing Pharmaceuticals, which sparked fury two months ago by increasing the price of the drug Daraprim, said Tuesday that it would not reduce the list price of that drug after all, reports The New York Times. Daraprim is a preferred treatment for toxoplasmosis, a rare parasitic infection that affects people with weak immune systems including…
